AstraZeneca PLC (AZN)
166.58
+2.02
(+1.23%)
USD |
NYSE |
Sep 25, 16:00
166.50
-0.08
(-0.05%)
Pre-Market: 19:59
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 516.68B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 15.23% |
| Valuation | |
| PE Ratio | 50.03 |
| PE Ratio (Forward) | |
| PS Ratio | 8.600 |
| Price to Book Value | 10.92 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.071 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.7166 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 27.87% |
Profile
| AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom. |
| URL | http://www.astrazeneca.com |
| Investor Relations URL | https://www.astrazeneca.com/investor-relations.html |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Large Cap Core |
| Next Earnings Release | Oct. 30, 2026 |
| Last Earnings Release | Jul. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 07, 2026 |
Profile
| AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom. |
| URL | http://www.astrazeneca.com |
| Investor Relations URL | https://www.astrazeneca.com/investor-relations.html |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Large Cap Core |
| Next Earnings Release | Oct. 30, 2026 |
| Last Earnings Release | Jul. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 07, 2026 |